Tim Forshew

Company: Inivata
Job title: Head of Science & Innovation and Co- Founder
Seminars:
13.00 | 11.00 – Practical Applications of ctDNA Testing for Residual Disease & Recurrence 1:00 pm
• RaDaR assay has industry leading sensitivity – why is this important? • Using residual disease and recurrence opens new options for clinical trial design • Data from a recent NSCLC clinical trialRead more
day: Day Two